{
    "Trade/Device Name(s)": [
        "diaDexus PLAC\u00ae test"
    ],
    "Submitter Information": "diaDexus, Inc.",
    "510(k) Number": "K062234",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050523"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NOE"
    ],
    "Summary Letter Date": "August 1, 2006",
    "Summary Letter Received Date": "August 23, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5600"
    ],
    "Regulation Name(s)": [
        "Low-density lipoprotein immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Lipoprotein-associated phospholipase A2 (Lp-PLA2)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "Kit",
        "Calibrator",
        "Antibody",
        "Reagent",
        "Microwell strip"
    ],
    "Document Summary": "FDA 510(k) summary for diaDexus PLAC\u00ae enzyme immunoassay test for quantitative measurement of Lp-PLA2 in human plasma and serum",
    "Indications for Use Summary": "Aid in predicting risk for coronary heart disease and ischemic stroke associated with atherosclerosis by quantitatively measuring Lp-PLA2 in human plasma and serum",
    "fda_folder": "Immunology"
}